UBR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.313800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.481200E-01
Normal-vs-Stage2
6.820000E-01
Normal-vs-Stage3
7.888100E-02
Normal-vs-Stage4
9.834200E-01
Stage1-vs-Stage2
6.152000E-01
Stage1-vs-Stage3
1.371710E-02
Stage1-vs-Stage4
9.784400E-01
Stage2-vs-Stage3
9.365500E-02
Stage2-vs-Stage4
6.626800E-01
Stage3-vs-Stage4
1.235550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.062600E-01
Normal-vs-AfricanAmerican
9.214600E-01
Normal-vs-Asian
4.676200E-01
Caucasian-vs-AfricanAmerican
3.718200E-01
Caucasian-vs-Asian
3.823800E-01
AfricanAmerican-vs-Asian
2.903800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.624400E-01
Normal-vs-Female
7.268200E-01
Male-vs-Female
4.174000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.716200E-01
Normal-vs-Age(41-60Yrs)
9.598400E-01
Normal-vs-Age(61-80Yrs)
5.137000E-01
Normal-vs-Age(81-100Yrs)
2.247400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.267400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.845600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.988560E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.005900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.218000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.662600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.278800E-01
Normal-vs-Daily Drinker
4.009200E-01
Normal-vs-Weekly Drinker
3.337200E-01
Normal-vs-Occasional Drinker
6.905800E-01
Normal-vs-Social Drinker
7.979400E-01
Non Drinker-vs-Daily Drinker
6.942000E-01
Non Drinker-vs-Weekly Drinker
5.487200E-01
Non Drinker-vs-Occasional Drinker
4.941800E-01
Non Drinker-vs-Social Drinker
3.645000E-01
Daily Drinker-vs-Weekly Drinker
8.328200E-01
Daily Drinker-vs-Occasional Drinker
3.594800E-01
Daily Drinker-vs-Social Drinker
2.782200E-01
Weekly Drinker-vs-Occasional Drinker
2.935600E-01
Weekly Drinker-vs-Social Drinker
2.306600E-01
Occasional Drinker-vs-Social Drinker
8.177000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.660000E-02
Normal-vs-Grade 2
6.696200E-03
Normal-vs-Grade 3
7.240200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.383200E-01
Grade 1-vs-Grade 3
2.959400E-01
Grade 1-vs-Grade 4
6.660000E-02
Grade 2-vs-Grade 3
3.715600E-01
Grade 2-vs-Grade 4
6.696200E-03
Grade 3-vs-Grade 4
7.240200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.604800E-01
Normal-vs-NonDiabetic
5.259800E-01
Diabetic-vs-NonDiabetic
4.551600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.322200E-01
Normal-vs-NoPancreatitis
5.319800E-01
Pancreatitis-vs-NoPancreatitis
9.192000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.141000E-01
Normal-vs-N1
7.182000E-01
N0-vs-N1
3.202400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.977600E-01
Normal-vs-TP53-NonMutant
9.195800E-01
TP53-Mutant-vs-TP53-NonMutant
7.277800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
